This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

10 A-Rated Large-Cap Dividend Stocks

NEW YORK (TheStreet) - The 10 large-cap stocks rated A-minus or higher by TheStreet Ratings with the highest dividend yields are all trading close to consensus price targets, but that's no surprise with such solid financials and rich dividend yields.

Starting with companies with market capitalizations exceeding $5 billion rated A-minus (strong buy) or higher by TheStreet Ratings, we pared down the group to the 10 stocks with the highest forward dividend yields, based on the most recent quarterly payout. Not surprisingly, electric utilities and energy service companies dominate the list. Total returns assume reinvested dividends.

10. Bristol-Myers Squibb

Company Profile

Bristol-Meyers Squibb is a global pharmaceutical company headquartered in New York. Shares closed at $27.68 Thursday with one-year total return - assuming dividends are reinvested - of 31%. Based on a quarterly payout of 32 cents, the shares have a forward dividend yield of 4.62%.

Income Statement

The company reported second-quarter net earnings to common stockholders of $927 million, or 53 cents a share, up from $743 million, or 43 cents a share, the previous quarter but down from $983 million, or 49 cents a share, a year earlier, when results included $103 million or 5 cents a share from discontinued operations.

Net sales for the second quarter were $4.8 billion, up 2% from a year earlier. During the second quarter, the company also began a $3 billion share repurchase program.

Balance Sheet

The company has strong liquidity with a quick ratio of 1.80, showing a clear ability to cover short term cash needs. The ratio of debt to capital is 0.29.

Stock Ratios

Shares trade for 11.4 times earnings, which is higher than the P/E for other major pharmaceuticals including Eli Lilly (LLY) which trades at 8.5 times earnings and Sanofi-Aventis SA (SNY) which is trading at 9.6 times earnings. Large-cap sector players trading at higher multiples include Abbot Laboratories (ABT)which trades for 14.9 times earnings and Teva Pharmaceutical (TEVA), which trades for 18.3 times earnings.

Analyst Ratings

Out of 25 analysts covering Bristol-Meyers Squibb, 11 rate the shares a buy, while 11 recommend investors hold and three recommend selling the shares.

Stock quotes in this article: S, BMY, LLY, ABT, CTL, SO, PGN 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 +2.54 0.14%
NASDAQ 4,095.5160 +9.2910 0.23%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs